korrents

On the map

Tap a claim on the ring to put it at the centre.

← Investment will keep draining out of cell and gene therapy until…

8 connected korrents · 8 moments on record from 1 Jan 2020 to 15 Aug 2026.

Everything filed under venture capital venture capital Same subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subject Read this korrent: Investment will keep draining out of cell and gene therapy until manufacturing and regulatory risk become possible to underwrite. Investment will keep draining out ofcell and gene therapy untilmanufacturing and regulatory riskbecome possible to underwrite. RT Ruxandra Teslo — holds since 2026-06-10 — tap for who they are Same subject: Nuclear plants should be financed with venture equity rather than project finance, because what is left is technology-execution risk and American venture capital is the best in the world at underwriting that. — tap to centre the map on it Nuclear plants should befinanced with venture equityrather than project finance,because what is left is… IT Isaiah Taylor — holds since 2026-08-15 — tap for who they are Same subject: AI factories and foundries are too capital-intensive for venture money; they need government or sovereign funds behind them. — tap to centre the map on it AI factories and foundries aretoo capital-intensive forventure money; they needgovernment or sovereign funds… LT Lip-Bu Tan — holds since 2026-06-18 — tap for who they are Same subject: Manufacturing and batch-release requirements, not biology, are what kill most promising cell and gene therapies. — tap to centre the map on it Manufacturing andbatch-release requirements,not biology, are what killmost promising cell and gene… RT Ruxandra Teslo — holds since 2026-06-10 — tap for who they are Same subject: AI will not on its own compress decades of medical progress into a few years, because the binding constraint is human data, clinical trials and regulation rather than intelligence. — tap to centre the map on it AI will not on its owncompress decades of medicalprogress into a few years,because the binding constraint… RT Ruxandra Teslo — holds since 2026-07-21 — tap for who they are JT Jacob Trefethen — holds since 2025-08-02 — tap for who they are Same subject: Not every bottleneck on medical progress is one AI can remove, and which ones will remain can be guessed at now. — tap to centre the map on it Not every bottleneck onmedical progress is one AI canremove, and which ones willremain can be guessed at now. JT Jacob Trefethen — holds since 2025-08-02 — tap for who they are Same subject: No country can keep a key technology to itself for long, because the knowledge leaves with the people who hold it. — tap to centre the map on it No country can keep a keytechnology to itself for long,because the knowledge leaveswith the people who hold it. DW Dan Wang — holds since 2020-01-01 — tap for who they are Same subject: Even a long-horizon deep tech company should chase revenue sooner than it thinks, so that it is valued on its roadmap rather than on its probability of dying. — tap to centre the map on it Even a long-horizon deep techcompany should chase revenuesooner than it thinks, so thatit is valued on its roadmap… MH Max Hodak — holds since 2026-08-07 — tap for who they are Same subject: There is no way to capture a new technology’s upside without being exposed to the losses if the enthusiasm proves excessive. — tap to centre the map on it There is no way to capture anew technology’s upsidewithout being exposed to thelosses if the enthusiasm… HM Howard Marks — holds since 2025-12-09 — tap for who they are
same subject or similar wordingshaded: claims sharing a subject

At the centre Investment will keep draining out of cell and gene therapy until manufacturing and regulatory risk become possible to underwrite. Holds Ruxandra Teslo Read this korrent →